Community-Acquired Pneumonia (CAP) Surveillance

NCT01416506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2013-11-05

No results posted yet for this study

Summary

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Conditions

Interventions

OTHER

No Drug

It's a surveillance

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-08-31
Completion
2013-01-31

Countries

  • China

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416506 on ClinicalTrials.gov